Olav Dalgård
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 2%
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 116
- Hepatitis C virus research 116
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Alessio Aghemo (4 shared papers)Heiner H. Wedemeyer (3 shared papers)Marina Berenguer (2 shared papers)Fiona Marra (2 shared papers)Massimo Puoti (2 shared papers)Geoffrey M Dusheiko (2 shared papers)Jean–Michel Pawlotsky (2 shared papers)Francesco Negro (2 shared papers)
In The Last Decade
Olav Dalgård
130 papers receiving 10.1k citations
Olav Dalgård's Hit Papers
Peers
Comparison fields: 5 of 128
- Hepatology 8.2k
- Epidemiology 1.2k
- Infectious Diseases 668
- Family Practice 55
- Immunology 309
Countries citing papers authored by Olav Dalgård
This map shows the geographic impact of Olav Dalgård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olav Dalgård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olav Dalgård more than expected).
Fields of papers citing papers by Olav Dalgård
This network shows the impact of papers produced by Olav Dalgård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olav Dalgård. The network helps show where Olav Dalgård may publish in the future.
Co-authors
The 25 scholars most cited alongside Olav Dalgård, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EASL Recommendations on Treatment of Hepatitis C 2018 Hit paper breakdown → | 2018 | 1759 |
| 2 | Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Hit paper breakdown → | 2016 | 1661 |
| 3 | EASL recommendations on treatment of hepatitis C: Final update of the series☆ Hit paper breakdown → | 2020 | 902 |
| 4 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Hit paper breakdown → | 2022 | 489 |
| 5 | 2011 | 336 | |
| 6 | 2016 | 309 | |
| 7 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 290 |
| 8 | 2004 | 255 | |
| 9 | 2011 | 248 | |
| 10 | 2018 | 233 | |
| 11 | 2021 | 218 | |
| 12 | 2015 | 163 | |
| 13 | 2007 | 155 | |
| 14 | 2016 | 144 | |
| 15 | 2019 | 138 | |
| 16 | 2017 | 131 | |
| 17 | 2011 | 121 | |
| 18 | 2002 | 114 | |
| 19 | 2015 | 114 | |
| 20 | 2016 | 114 |
About Olav Dalgård
Olav Dalgård is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Family Practice and Applied Microbiology and Biotechnology, having authored 143 papers that have together received 10.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (116 papers), COVID-19 Clinical Research Studies (11 papers), Hepatitis B Virus Studies (7 papers), HIV, Drug Use, Sexual Risk (5 papers), Medication Adherence and Compliance (2 papers), Opioid Use Disorder Treatment (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Hepatology (8.2k citations), Epidemiology (1.2k citations), Infectious Diseases (668 citations), Family Practice (55 citations) and Immunology (309 citations). Olav Dalgård has collaborated with scholars based in Norway, Australia and Sweden. Frequent co-authors include Alessio Aghemo, Heiner H. Wedemeyer, Marina Berenguer, Fiona Marra, Massimo Puoti, Geoffrey M Dusheiko, Jean–Michel Pawlotsky, Francesco Negro, Kjell Skaug and Håvard Midgard. Their work appears in journals such as Journal of Hepatology, International Journal of Drug Policy, Clinical Infectious Diseases, Hepatology and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.